|
GMCL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.138400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.804400E-01 |
| Normal-vs-Stage2 |
6.140200E-01 |
| Normal-vs-Stage3 |
5.949200E-01 |
| Normal-vs-Stage4 |
4.913000E-01 |
| Stage1-vs-Stage2 |
5.541800E-01 |
| Stage1-vs-Stage3 |
6.558000E-01 |
| Stage1-vs-Stage4 |
5.384200E-01 |
| Stage2-vs-Stage3 |
4.211600E-01 |
| Stage2-vs-Stage4 |
3.585800E-01 |
| Stage3-vs-Stage4 |
8.539800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.439400E-01 |
| Normal-vs-AfricanAmerican |
5.156600E-03 |
| Normal-vs-Asian |
8.869600E-01 |
| Caucasian-vs-AfricanAmerican |
1.138240E-02 |
| Caucasian-vs-Asian |
9.453400E-01 |
| AfricanAmerican-vs-Asian |
2.883400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.752400E-01 |
| Normal-vs-Female |
6.139000E-01 |
| Male-vs-Female |
1.972570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.958300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.329800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.603200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.107200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.001990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.292400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.736000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.507200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.543400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.481000E-01 |
| Normal-vs-Grade 2 |
3.487400E-01 |
| Normal-vs-Grade 3 |
6.637600E-01 |
| Normal-vs-Grade 4 |
6.023200E-03 |
| Grade 1-vs-Grade 2 |
5.961600E-01 |
| Grade 1-vs-Grade 3 |
9.108800E-01 |
| Grade 1-vs-Grade 4 |
1.968410E-01 |
| Grade 2-vs-Grade 3 |
1.913180E-01 |
| Grade 2-vs-Grade 4 |
1.378640E-03 |
| Grade 3-vs-Grade 4 |
2.418300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.427800E-02 |
| Normal-vs-ccB subtype |
1.831170E-01 |
| ccA subtype-vs-ccB subtype |
1.180920E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.079200E-01 |
| Normal-vs-N1 |
9.974000E-01 |
| N0-vs-N1 |
9.314000E-01 |
|
|
